Execs On The Move, September 2013
Executive Summary
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, including Sanofi's Sarclisa for treating adults with relapsed and refractory multiple myeloma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).
Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
Aurobindo Upbeat On Outlook, Transfers Biologics Biz
After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.
Need a specific report? 1000+ reports available
Buy Reports